Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| m6A RNA Methylation in Psychiatric Disorders: An Emerging Epitranscriptomic Axis. | Epigenomes | 2025 | 40981072 | PubTator, text mining | PubMed |
| Yes-associated protein 1 in cancer: bridging mechanical transduction and epigenetic regulation. | Cancer Biol Ther | 2025 | 40977060 | PubTator, text mining | PubMed |
| METTL14 Inhibits the Pyroptosis of Neurons in Parkinson's Disease via Upregulating NFE2. | Crit Rev Eukaryot Gene Expr | 2025 | 40972098 | PubTator, text mining | PubMed |
| Maintenance of neuronal TDP-43 expression requires axonal lysosome transport. | Elife | 2025 | 40970386 | PubTator, text mining | PubMed |
| Epigenetics in neonatal necrotizing enterocolitis: current understanding and the potential involvement of m6A modification. | Front Pediatr | 2025 | 40963968 | PubTator, text mining | PubMed |
| USP38: an important regulatory factor in tumor malignant progression. | Front Immunol | 2025 | 40936898 | PubTator, text mining | PubMed |
| Verbascoside inhibits OGD/R-induced SK-N-SH cell injury by regulating METTL14/CHAC1/NRF2/SLC7A11/GPX4 pathway. | Brain Res Bull | 2025 | 40935194 | PubTator, text mining | PubMed |
| Analysis of the mRNA modification machinery alterations in breast cancer through the SCAN-B cohort. | NAR Cancer | 2025 | 40918643 | PubTator, text mining | PubMed |
| The role of N6-methyladenosine (m6A) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential. | PeerJ | 2025 | 40895041 | PubTator, text mining | PubMed |
| IDH1-dependent m6A methylation defines transcriptomic heterogeneity in glioma. | medRxiv | 2025 | 40894120 | PubTator, text mining | PubMed |
| CUB domain-containing protein 1 signaling dysregulates gemcitabine metabolism contributing to therapeutic resistance in T24 cells. | PLoS One | 2025 | 40892739 | PubTator, text mining | PubMed |
| Identification and experimental validation of biomarkers related to mitochondrial and programmed cell death in obsessive-compulsive disorder. | Sci Rep | 2025 | 40885831 | PubTator, text mining | PubMed |
| Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis. | Cell Death Dis | 2025 | 40885716 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of circCDKAL1 regulates macrophage M1 polarization and nasal epithelial cell barrier function in allergic rhinitis through IGF2BP2/JARID2/HMGB1 axis. | Cell Death Discov | 2025 | 40883266 | PubTator, text mining | PubMed |
| YTHDF3-associated m6A regulation and cuproptosis-related gene expression in steroid-induced osteonecrosis of the femoral head. | J Mol Histol | 2025 | 40879675 | PubTator, text mining | PubMed |
| Glycyrrhizic Acid Ameliorates LPS-Induced WI-38 Cell Inflammation, Oxidative Stress, and Ferroptosis via Targeting METTL14 in Infantile Pneumonia. | Clin Exp Pharmacol Physiol | 2025 | 40873099 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic and m6A Epitranscriptomic Analysis Reveals Colchicine-Induced Kidney Toxicity via DNA Damage and Autophagy in HK2 Cells. | Toxins (Basel) | 2025 | 40864084 | PubTator, text mining | PubMed |
| METTL14-mediated m6A methylation promotes macrophage M2 polarization via YTHDF1-Socs1 axis to accelerate skin wound healing. | Eur J Med Res | 2025 | 40859253 | PubTator, text mining | PubMed |
Methyltransferase-like 14 (METTL14)-mediated N6-methyladenosine (m6A) Modification of Forkhead Box Protein 1 (FOXP1) Regulates Trophoblast Inflammation and Function via Transmembrane BAX Inhibitor Motif-Containing 6 (TMBIM6). | J Biochem Mol Toxicol | 2025 | 40852886 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=13